Bristol-Myers Squibb (NYSE: BMY) reported earnings on Oct. 24. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended Sep. 30 (Q3), Bristol-Myers Squibb missed estimates on revenues and missed estimates on earnings per share.

Compared to the prior-year quarter, revenue shrank significantly and GAAP earnings per share shrank to a loss.

Margins dropped across the board.

Revenue details
 Bristol-Myers Squibb reported revenue of $3.74 billion. The 15 analysts polled by S&P Capital IQ expected revenue of $3.97 billion on the same basis. GAAP reported sales were 30% lower than the prior-year quarter's $5.35 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.41. The 17 earnings estimates compiled by S&P Capital IQ averaged $0.42 per share. GAAP EPS were -$0.43 for Q3 compared to $0.56 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 73.6%, 40 basis points worse than the prior-year quarter. Operating margin was 15.0%, 1,960 basis points worse than the prior-year quarter. Net margin was -19.0%, 3,710 basis points worse than the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $4.22 billion. On the bottom line, the average EPS estimate is $0.40.

Next year's average estimate for revenue is $17.83 billion. The average EPS estimate is $1.94.

Investor sentiment
 The stock has a five-star rating (out of five) at Motley Fool CAPS, with 1,701 members out of 1,811 rating the stock outperform, and 110 members rating it underperform. Among 474 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 455 give Bristol-Myers Squibb a green thumbs-up, and 19 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Bristol-Myers Squibb is hold, with an average price target of $34.88.

Can your portfolio provide you with enough income to last through retirement? You'll need more than Bristol-Myers Squibb. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.